What does DR. KIEKENS do?

DR. KIEKENS is a specialist medical practice in Schoten. Private Limited, started on 8 April 2004, 2 establishments.

What is the address of DR. KIEKENS?

The registered office of DR. KIEKENS is located at Gaaiendreef 12, 2900 Schoten.

Is DR. KIEKENS still active?

Yes. According to the CBE (1 October 2026) DR. KIEKENS is active, legal situation “Normale toestand”, started on 8 April 2004.

Is DR. KIEKENS registered on Peppol?

Yes, DR. KIEKENS is registered on the Peppol network with ID 0208:0864615735.

What is the enterprise number of DR. KIEKENS?

The enterprise number of DR. KIEKENS is BE0864615735.

When was DR. KIEKENS founded?

DR. KIEKENS was founded on 8 April 2004.

Who are the directors of DR. KIEKENS?

According to the 2025 annual accounts, the directors of DR. KIEKENS are: Gunther Kiekens, Sabrina Robbens.

Is DR. KIEKENS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 April 2004; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. KIEKENS make in 2025?

DR. KIEKENS posted a profit after taxes of € 94,706 in financial year 2025.

What is the revenue of DR. KIEKENS?

As a small company, DR. KIEKENS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 272,808.

DR. KIEKENS (Private Limited) - Schoten - BE0864615735

Dossier DR. KIEKENS, printed on 1 October 2026 from databakkes.be/en/0864615735/dr-kiekens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. KIEKENS from Schoten, company number BE0864615735, closed financial year 2025 with a result of € 94,706 after tax. For that financial year DR. KIEKENS recorded a gross margin of € 272,808 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 70,263 to € 94,706. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 29, 2026.

What it is worth Growing

€ 1.2 million

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 94,706

▲ 35% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 128

▼ 64% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 10,000 paid out

11 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,913

▲ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 360,580

▼ 15% vs 2024

€ 101,448 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 7,495

▲ 188% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 31,299

▲ 130% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 279,401 Gross margin 2022: € 279,401 First fiscal year in the series	€ 229,134 Gross margin 2023: € 229,134 ▼ 18% vs 2022 (€ 279,401) Unfavourable step	€ 272,373 Gross margin 2024: € 272,373 ▲ 19% vs 2023 (€ 229,134) Favourable step	€ 272,808 Gross margin 2025: € 272,808 Unchanged (€ 272,373) Favourable step
Profit after taxes	€ 88,824 Profit after taxes 2022: € 88,824 First fiscal year in the series	€ -19,502 Profit after taxes 2023: € -19,502 ▼ € 108,326 vs 2022 (€ 88,824) Unfavourable step	€ 70,263 Profit after taxes 2024: € 70,263 ▲ € 89,765 vs 2023 (€ -19,502) Favourable step	€ 94,706 Profit after taxes 2025: € 94,706 ▲ 35% vs 2024 (€ 70,263) Favourable step	▲ 35%
Equity	€ 1,070,718 Equity 2022: € 1,070,718 First fiscal year in the series	€ 1,051,215 Equity 2023: € 1,051,215 ▼ 2% vs 2022 (€ 1,070,718) Unfavourable step	€ 1,102,878 Equity 2024: € 1,102,878 ▲ 5% vs 2023 (€ 1,051,215) Favourable step	€ 1,187,584 Equity 2025: € 1,187,584 ▲ 8% vs 2024 (€ 1,102,878) Favourable step	▲ 8%
Total debts	€ 667,956 Total debts 2022: € 667,956 First fiscal year in the series	€ 560,489 Total debts 2023: € 560,489 ▼ 16% vs 2022 (€ 667,956) Favourable step	€ 453,392 Total debts 2024: € 453,392 ▼ 19% vs 2023 (€ 560,489) Favourable step	€ 409,374 Total debts 2025: € 409,374 ▼ 10% vs 2024 (€ 453,392) Favourable step	▼ 10%
Cash	€ 44,548 Cash 2022: € 44,548 First fiscal year in the series	€ 36,759 Cash 2023: € 36,759 ▼ 17% vs 2022 (€ 44,548) Unfavourable step	€ 350 Cash 2024: € 350 ▼ 99% vs 2023 (€ 36,759) Unfavourable step	€ 128 Cash 2025: € 128 ▼ 64% vs 2024 (€ 350) Unfavourable step	▼ 64%
Land & buildings	€ 1,329,913 Land & buildings 2022: € 1,329,913 First fiscal year in the series	€ 1,257,190 Land & buildings 2023: € 1,257,190 ▼ 5% vs 2022 (€ 1,329,913) Unchanged	€ 1,161,291 Land & buildings 2024: € 1,161,291 ▼ 8% vs 2023 (€ 1,257,190) Unchanged	€ 1,099,553 Land & buildings 2025: € 1,099,553 ▼ 5% vs 2024 (€ 1,161,291) Unchanged	▼ 5%
Retained profit	€ 1,052,118 Retained profit 2022: € 1,052,118 First fiscal year in the series	€ 1,032,615 Retained profit 2023: € 1,032,615 ▼ 2% vs 2022 (€ 1,052,118) Unfavourable step	€ 1,102,878 Retained profit 2024: € 1,102,878 ▲ 7% vs 2023 (€ 1,032,615) Favourable step	€ 1,187,584 Retained profit 2025: € 1,187,584 ▲ 8% vs 2024 (€ 1,102,878) Favourable step	▲ 8%
Dividend	€ 30,000 Dividend 2022: € 30,000 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 30,000) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 10,000 Dividend 2025: € 10,000 Unchanged (€ 0) Unchanged
Bank debt	€ 653,934 Bank debt 2022: € 653,934 First fiscal year in the series	€ 514,579 Bank debt 2023: € 514,579 ▼ 21% vs 2022 (€ 653,934) Favourable step	€ 423,598 Bank debt 2024: € 423,598 ▼ 18% vs 2023 (€ 514,579) Favourable step	€ 360,580 Bank debt 2025: € 360,580 ▼ 15% vs 2024 (€ 423,598) Favourable step	▼ 15%
Balance sheet total	€ 1,738,674 Balance sheet total 2022: € 1,738,674 First fiscal year in the series	€ 1,611,704 Balance sheet total 2023: € 1,611,704 ▼ 7% vs 2022 (€ 1,738,674) Unchanged	€ 1,556,270 Balance sheet total 2024: € 1,556,270 ▼ 3% vs 2023 (€ 1,611,704) Unchanged	€ 1,596,958 Balance sheet total 2025: € 1,596,958 ▲ 3% vs 2024 (€ 1,556,270) Unchanged	▲ 3%

Key figures of DR. KIEKENS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to DR. KIEKENS?

What happened at DR. KIEKENS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 29, 2026 New annual accounts for financial year 2025: profit of € 94,706 (▲ 35% vs 2024). Source: NBB ↗
2023 Sabrina Robbens became a director. NBB
Jul 1, 2007 New establishment in Schoten. KBO
Apr 8, 2004 Start of the company according to the CBE. KBO
Apr 1, 2004 New establishment in Mechelen. KBO
2004 Gunther Kiekens became a director. NBB

In short

From € 88,824 profit in 2022 to € 94,706 profit in 2025.

Paid € 178,922 in corporate taxes since 2022.

Best year ever: 2025, with € 94,706 profit.

Paid out € 40,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. KIEKENS? We notify you, reason included.

Follow DR. KIEKENS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gunther Kiekens Sabrina Robbens

DR. KIEKENS

Behind DR. KIEKENS are Gunther Kiekens and Sabrina Robbens.

See the full network in the app

Directors

According to the 2025 annual accounts

Gunther Kiekens

Director

since 2004

Sabrina Robbens

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Gaaiendreef 12

2900 Schoten

2.232.142.026

Veemarkt 54

2800 Mechelen

Active since 1 April 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0864.615.735
VAT number: BE 0864.615.735
Registered office: Gaaiendreef 12, 2900 Schoten
Names & denominations: DR. KIEKENS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 April 2004
Peppol: Active · Active since 5 Jan 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗